Get to Know

Professor Greg Shaw

I am Professor of Urology at University College London and built and led Robotic Urology at University College London Hospitals from 2020-2025. I work privately at The Prostate Centre and The Princess Grace Hospital.

I qualified in medicine at St Bartholomew’s Medical College in 1999. My focus on prostate cancer started with an MD research degree at St Bartholomew's Hospital in 2005. Thereafter I trained as a urologist in North London where I earned Fellowship of the Royal College of Surgeons. I am listed on the specialist register of the GMC for Urology (GMC number: 4626222).

In order to further develop my interest in prostate cancer I took up a four year Lectureship at The University of Cambridge working in a world class research team and generating important findings from my research.

In Cambridge I began to develop my interest in robotic surgery that was consolidated through the prestigious Royal College of Surgeons of England Fellowship program from which I graduated in 2015. I run an active research program focused on improving outcomes from robotic radical prostatectomy.

Accomplishments and Leadership

I have personally performed over 1400 robotic radical prostatectomies. I perform 150 robotic prostatectomies per year, amongst the highest rate for UK urologists. I strive to evaluate and incorporate the best technical modifications to attain excellent results for my patients. I pride myself on my very low complication rate and strive for excellent outcomes.

My academic focus is to improve the way men are diagnosed and treated for prostate cancer. In 2022 I was awarded a Professor of Urology at University College London. From 2020-2024 I led the NIHR study to evaluate the effects of aspirin and vitamin D on prostate cancer progression for men being treated with active surveillance. Currently I lead the NeuroSAFE PROOF study to evaluate the cost effectiveness of the NeuroSAFE procedure during radical prostatectomy and the C-PRO-META study to evaluate the prognostic utility of circulating tumour cells in men undergoing surgery for prostate cancer. I have developed a technique called complete urethral preservation (or CUP) to promote continence after radical prostatectomy.

I lead the largest NHS pelvic robotic surgery team in the UK. We achieve world class results.

I am the lead for Urology for the National Institute for Health Research (the research arm of the NHS) for North Thames. I was part of the team responsible for training the staff for the NHS Nightingale Hospital in London during the COVID crisis.

Urological conditions for which
he consults include

Prostate cancer diagnostics
Prostate cancer MRI
Prostate biopsy
Transperineal prostate biopsy
Targeted prostate biopsy
Robotic prostatectomy
Active surveillance
Recurrent urinary tract infection
Difficulty passing urine
Blood in the urine
Raised PSA
Testis lumps
Low testosterone (andropause)
Erectile dysfunction

Greg Shaw has strong links to The Orchid Cancer Appeal for whom he is a fundraiser and spokesperson.